Research and analysis

NERVTAG: note on growth rate of SARS-CoV-2 B.1.1.7, 22 April 2021

Paper from the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) on the COVID-19 variant B.1.1.7.

Documents

NERVTAG: note on growth rate of SARS-CoV-2 B.1.1.7, 22 April 2021

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email contact@go-science.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Paper prepared by NERVTAG on the B.1.1.7 SARS-CoV-2 variant of concern. It was considered at SAGE 87 on 22 April 2021.

As new evidence or data emerges, SAGE updates its advice accordingly.

See more information on new variants of concern.

The following members of NERVTAG authored this paper: Peter Horby, Cariad Evans, Catherine Huntley, Muge Cevik, Wendy Barclay, Julian Hiscox, John Edmunds, Neil Ferguson, Andrew Hayward and Maria Zambon.

These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.

Updates to this page

Published 30 April 2021

Sign up for emails or print this page